Understanding the basis for acquired resistance to KRASG12C inhibitors

被引：0
|
作者：
Santos Ramos, A. [1 ]
Gomez Sanchez, D. [1 ]
Rico Lopez, S. [1 ]
Plaza Exposito, P. [1 ]
Paz-Ares, L. [2 ]
Ferrer Sanchez, I. [1 ]
机构：
[1] Inst Invest Sanitaria Hosp 12 Octubre, Madrid, Spain
[2] Hosp Univ 12 Octubre, Med Oncol Dept Edificio Maternidad, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 08期
关键词：
D O I：
10.1016/j.annonc.2022.09.092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1411 / S1411
页数：1
相关论文
共 50 条
  • [31] KRasG12C inhibitors in clinical trials: a short historical perspective
    Goebel, Lisa
    Mueller, Matthias P.
    Goody, Roger S.
    Rauh, Daniel
    RSC MEDICINAL CHEMISTRY, 2020, 11 (07): : 760 - 770
  • [32] Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance
    Thatikonda, Venu
    Lyu, Hengyu
    Jurado, Sabine
    Kostyrko, Kaja
    Bristow, Christopher A.
    Albrecht, Christoph
    Alpar, Donat
    Arnhof, Heribert
    Bergner, Oliver
    Bosch, Karin
    Feng, Ningping
    Gao, Sisi
    Gerlach, Daniel
    Gmachl, Michael
    Hinkel, Melanie
    Lieb, Simone
    Jeschko, Astrid
    Machado, Annette A.
    Madensky, Thomas
    Marszalek, Ethan D.
    Mahendra, Mikhila
    Melo-Zainzinger, Gabriella
    Molkentine, Jessica M.
    Jaeger, Philipp A.
    Peng, David H.
    Schenk, Robyn L.
    Sorokin, Alexey
    Strauss, Sandra
    Trapani, Francesca
    Kopetz, Scott
    Vellano, Christopher P.
    Petronczki, Mark
    Kraut, Norbert
    Heffernan, Timothy P.
    Marszalek, Joseph R.
    Pearson, Mark
    Waizenegger, Irene C.
    Hofmann, Marco H.
    NATURE CANCER, 2024, 5 (09) : 1352 - 1370
  • [33] Covalent inhibitors of the GTPase KRASG12C: a review of the patent literature
    Kettle, Jason G.
    Cassar, Doyle J.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (02) : 103 - 120
  • [34] Characterization of Kinetic and Redox Properties of Oncogenic KRASG12C Inhibitors
    Campbell, Sharon
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 208 : S100 - S101
  • [35] The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
    Albert K. Kwan
    Gary A. Piazza
    Adam B. Keeton
    Caio A. Leite
    Journal of Experimental & Clinical Cancer Research, 41
  • [36] TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC
    Tammaccaro, Salvina Laura
    Prigent, Philippe
    Le Bail, Jean-Christophe
    Dos-Santos, Odette
    Dassencourt, Laurent
    Eskandar, Myriam
    Buzy, Armelle
    Venier, Olivier
    Guillemot, Jean-Claude
    Veeranagouda, Yaligara
    Didier, Michel
    Spanakis, Emmanuel
    Kanno, Tokuwa
    Cesaroni, Matteo
    Mathieu, Stephane
    Canard, Luc
    Casse, Alhassan
    Windenberger, Fanny
    Calvet, Loreley
    Noblet, Laurence
    Sidhu, Sukhvinder
    Debussche, Laurent
    Moll, Jurgen
    Valtingojer, Iris
    PHARMACEUTICALS, 2023, 16 (04)
  • [37] Targeting transcriptional elongation kinases prevents adaptation to KRASG12C inhibitors in both MAPK-dependent and -independent models of acquired resistance
    Stern, Yaakov E.
    Ghosh, Pompom
    Solanki, Hitendra S.
    Imbody, Denis
    Bridenstine, Liznair
    Walker-Mimms, Hannah L.
    Mosior, John W.
    Monastyrskyi, Andrii
    Duckett, Derek R.
    Haura, Eric B.
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [38] Vertical inhibition overcomes adaptive resistance to KRASG12C inhibition
    Ryan, Meagan B.
    de la Cruz, Ferran Fece
    Phat, Sarah
    Myers, David T.
    Shahzade, Heather A.
    Hong, Catriona B.
    Corcoran, Ryan B.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [39] TUSC2 gene therapy in KRASG12C mutant NSCLC overcomes acquired resistance to sotorasib
    Meraz, I.
    Majidi, M.
    Gao, L.
    Ren, C.
    Wu, S.
    Song, R.
    Meng, F.
    Xu, Y.
    Wang, Q.
    Xi, Y.
    Wang, J.
    Jung, S. Y.
    Shpall, E.
    Roth, J. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S145 - S145
  • [40] The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors
    Rasmus Hansen
    Ulf Peters
    Anjali Babbar
    Yuching Chen
    Jun Feng
    Matthew R. Janes
    Lian-Sheng Li
    Pingda Ren
    Yi Liu
    Patrick P. Zarrinkar
    Nature Structural & Molecular Biology, 2018, 25 : 454 - 462
12345